Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-small Cell Lung Cancer Metastatic 1

Interventions

Cisplatin 516 Radiotherapy 378 Cyclophosphamide 368 Carboplatin 359 Capecitabine 341 Paclitaxel 336 Oxaliplatin 335 Gemcitabine 323 Docetaxel 316 Fluorouracil 289 Drug Therapy 276 apatinib 247 Bevacizumab 247 camrelizumab 219 Etoposide 201 Irinotecan 181 Doxorubicin 181 Leucovorin 163 Dexamethasone 161 pembrolizumab 153 Neoadjuvant Therapy 146 sintilimab 145 Blood Specimen Collection 140 anlotinib 139 Pemetrexed 138 Cytarabine 138 toripalimab 134 Surgical Procedures, Operative 131 Radiosurgery 130 S 1 (combination) 125

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × GC Temporary Stopping × Clear all

NCT06127940 2023-11-13

K-SAB

Karolinska University Hospital

Phase 1 Unknown

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡